Alberta Investment Management Corp Ironwood Pharmaceuticals Inc Transaction History

Alberta Investment Management Corp

$10.2 Billion
Q3 2024

A detailed history of Alberta Investment Management Corp transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Alberta Investment Management Corp holds 210,731 shares of IRWD stock, worth $743,880. This represents 0.01% of its overall portfolio holdings.

Number of Shares

210,731

Previous 210,731 -0.0%

Holding current value

$743,880

Previous $1.37 Million 36.93%

% of portfolio

0.01%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $138,063 - $189,942	-16,735 Reduced 7.36%	210,731 $2.03 Million
Q2 2023 Aug 14, 2023	SELL	$10.1 - $11.6 $393,081 - $451,460	-38,919 Reduced 14.61%	227,466 $2.42 Million
Q1 2023 May 15, 2023	BUY	$10.37 - $12.56 $222,094 - $268,997	21,417 Added 8.74%	266,385 $2.8 Million
Q4 2022 Feb 14, 2023	SELL	$9.9 - $12.43 $221,245 - $277,785	-22,348 Reduced 8.36%	244,968 $3.04 Million
Q3 2022 Nov 14, 2022	BUY	$10.14 - $12.38 $76,952 - $93,951	7,589 Added 2.92%	267,316 $2.77 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $17,680 - $20,352	-1,600 Reduced 0.61%	259,727 $3 Million
Q1 2022 May 16, 2022	SELL	$10.61 - $12.88 $15,055 - $18,276	-1,419 Reduced 0.54%	261,327 $3.29 Million
Q4 2021 Feb 11, 2022	BUY	$10.86 - $13.95 $564,882 - $725,609	52,015 Added 24.68%	262,746 $3.06 Million
Q3 2021 Nov 15, 2021	BUY	$11.92 - $13.92 $672,335 - $785,143	56,404 Added 36.55%	210,731 $2.75 Million
Q2 2021 Aug 16, 2021	BUY	$10.16 - $13.11 $1.57 Million - $2.02 Million	154,327 New	154,327 $1.99 Million
Q4 2020 Feb 16, 2021	SELL	$9.05 - $12.2 $915,860 - $1.23 Million	-101,200 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$8.99 - $10.74 $909,788 - $1.09 Million	101,200 New	101,200 $910,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Account

Alberta Investment Management Corp Ironwood Pharmaceuticals Inc Transaction History